Gunjan Bhardwaj is the Founder and CEO of Innoplexus, an AI and Data Analytics-as-a-service provider for pharmaceutical companies. Innoplexus leverages AI to normalize unstructured data for drug research and development. The result is faster clinical trials with higher success rates, leading to less expensive drugs and greater patient outcomes. Before founding Innoplexus, Gunjan was a manager of Earnst & Young’s German practice, where he led their global business performance think-tank. Prior to that, he worked with Boston Consulting Group.